Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Tennessee

275 recruiting clinical trials across 15 cities in Tennessee (TN). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
275
Total Trials
275
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Tennessee

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00341744

Providing Access to the Visual Environment

Providing Access to the Visual Environment is a pediatric low vision grant which has the ability to provide comprehensive, interdisciplinary low vision rehabilitation services to...

Sponsor: Vanderbilt UniversityEnrolling: 7951 location
Vision Impairment
RECRUITINGNCT00575081

Physiological Brain Atlas Development

The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data...

Sponsor: Vanderbilt University Medical CenterEnrolling: 50001 location
Parkinson's DiseaseObsessive Compulsive DisorderDystonia+2
RECRUITINGNCT01205815

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Sponsor: Vanderbilt-Ingram Cancer CenterEnrolling: 30001 location
Melanoma
RECRUITINGNCT01860339

Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease

Huntington's Disease (HD) is an autosomal dominant disease manifested in a triad of cognitive, psychiatric, and motor signs and symptoms. HD is caused by a triplet repeat...

Sponsor: Peggy C NopoulosEnrolling: 4006 locations
Huntington's Disease
RECRUITINGNCT01884051

Hormonal, Metabolic, and Signaling Interactions in PAH

Our hypothesis is that optimal treatment of the dysfunctional metabolic pathways which underlie PAH will improve pulmonary vascular function and consequences of the disease.

Sponsor: Vanderbilt University Medical CenterEnrolling: 18991 location
Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionScleroderma Associated Pulmonary Arterial Hypertension+1
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGNCT02098863

Sickle Cell Clinical Research and Intervention Program

Despite the important work of previous sickle cell disease (SCD) cohort studies, there remain many understudied areas that require investigation. An important knowledge deficit is...

Sponsor: St. Jude Children's Research HospitalEnrolling: 100006 locations
Sickle Cell Disease
RECRUITINGPhase 1 / Phase 2NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 112020 locations
HIV Infection
RECRUITINGPhase 1 / Phase 2NCT02343042

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of...

Sponsor: Karyopharm Therapeutics INCEnrolling: 30020 locations
Multiple Myeloma
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGPhase 1NCT02646475

Metabolic Effects of Angiotensin-(1-7)

The overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic...

Sponsor: Vanderbilt UniversityEnrolling: 261 location
ObesityInsulin ResistanceHypertension+1
RECRUITINGNCT02720679

Investigation of the Genetics of Hematologic Diseases

The purpose of this study is to collect and store samples and health information for current and future research to learn more about the causes and treatment of blood diseases....

Sponsor: St. Jude Children's Research HospitalEnrolling: 17161 location
Bone Marrow Failure SyndromesErythrocyte DisorderLeukocyte Disorder+10
RECRUITINGNCT02775643

Molecular Analysis of Childhood and Adolescent Melanocytic Lesions

This is an observational, non-therapeutic study to collect clinical and molecular information of pediatric patients with childhood melanocytic lesions. PRIMARY OBJECTIVE: To...

Sponsor: St. Jude Children's Research HospitalEnrolling: 5001 location
Melanoma
RECRUITINGNCT02855476

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for...

HDClarity will seek at least 2500 research participants at different stages of Huntington's disease (HD). The primary objective is to collect a high quality CSF sample for...

Sponsor: University College, LondonEnrolling: 250020 locations
Huntington's Disease
RECRUITINGPhase 2NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...

Sponsor: Gilead SciencesEnrolling: 15020 locations
Chronic Hepatitis B
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGNCT03050268

Familial Investigations of Childhood Cancer Predisposition

NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many...

Sponsor: St. Jude Children's Research HospitalEnrolling: 15001 location
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGNCT03312556

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of...

Sponsor: Vanderbilt University Medical CenterEnrolling: 121 location
Supine HypertensionAutonomic Failure
RECRUITINGNCT03353584

Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Acute vaso-occlusive crisis (VOC) is the most common complication in patients with sickle cell disease (SCD) and pain related to VOC is often inadequately treated. This is a phase...

Sponsor: St. Jude Children's Research HospitalEnrolling: 762 locations
Sickle Cell DiseaseVaso-occlusive Crisis
RECRUITINGPhase 3NCT03401398

Stress Hydrocortisone In Pediatric Septic Shock

SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive...

Sponsor: Jerry ZimmermanEnrolling: 50020 locations
Septic Shock
RECRUITINGNCT03437486

Mechanisms of Familial Pulmonary Fibrosis

This a prospective, longitudinal study of first-degree family members of patients diagnosed with familial interstitial pneumonia (FIP). FIP is the familial form of idiopathic...

Sponsor: Vanderbilt University Medical CenterEnrolling: 7501 location
Familial Pulmonary FibrosisIdiopathic Pulmonary FibrosisFamilial Interstitial Pneumonia
RECRUITINGNCT03686709

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion of Y90 microspheres...

Sponsor: University of TennesseeEnrolling: 201 location
Hepatocellular CarcinomaRadiation Exposure
RECRUITINGNCT03941379

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care...

Sponsor: Aura BiosciencesEnrolling: 50016 locations
Choroidal MelanomaIndeterminate Lesions of Eye
RECRUITINGPhase 1 / Phase 2NCT03947385

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

This is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harboring GNAQ or GNA11...

Sponsor: IDEAYA BiosciencesEnrolling: 33615 locations
Metastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1
RECRUITINGPhase 1 / Phase 2NCT04094610

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies...

Sponsor: Turning Point Therapeutics, Inc.Enrolling: 7520 locations
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1
RECRUITINGNCT04165109

Trial-Ready Cohort-Down Syndrome (TRC-DS)

The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC),...

Sponsor: University of Southern CaliforniaEnrolling: 55020 locations
Down SyndromeAlzheimer DiseaseDementia
RECRUITINGPhase 1 / Phase 2NCT04195347

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

This is a phase I/II clinical trial assessing the tolerability and efficacy of CM4620 in children and young adults with acute pancreatitis caused by asparaginase. The tolerability...

Sponsor: St. Jude Children's Research HospitalEnrolling: 422 locations
Acute Pancreatitis
RECRUITINGPhase 4NCT04373317

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients...

Sponsor: VA Office of Research and DevelopmentEnrolling: 35820 locations
Parkinson's Disease Psychosis
RECRUITINGNCT04416178

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

The primary objectives of this prospective mixed-method interview study are to use semi-structured interviews in parents of sickle cell disease (SCD) patients to describe parental...

Sponsor: St. Jude Children's Research HospitalEnrolling: 3521 location
Sickle Cell Disease

Showing 30 of 275 trials in Tennessee. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 275 clinical trials actively recruiting participants in Tennessee. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Tennessee include Sickle Cell Disease, Colorectal Cancer, Melanoma, Pancreatic Cancer, Ovarian Cancer. Each has multiple active trials across research centers in the state.

Major trial sites in Tennessee include Nashville, Memphis, Knoxville, Chattanooga, Germantown. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.